BB Biotech AG (XSWX:BION) 3-1 Month Momentum %: -6.25% (As of Jul. 15, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:BION BB Biotech AG XSWX:BION
34 GF Score
Price CHF50.10
! 4 Warning Signs
View Full Analysis

What is BB Biotech AG 3-1 Month Momentum %?

BB Biotech AG XSWX:BION -0.60% 34 3-1 Month Momentum % is -6.25% as of Jul. 15, 2026. GuruFocus rates XSWX:BION with a GF Score™ of 34/100. The stock has 4 warning signs investors should review. Among 1,385 Biotechnology companies, BB Biotech AG ranks better than 56.03% on this metric.

3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-07-15), BB Biotech AG's 3-1 Month Momentum % is -6.25%.

The industry rank for BB Biotech AG's 3-1 Month Momentum % or its related term are showing as below:

XSWX:BION's 3-1 Month Momentum % is ranked better than
56.03% of 1385 companies
in the Biotechnology industry
Industry Median: -10.59 vs XSWX:BION: -6.25

BB Biotech AG  (XSWX:BION) 3-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.

BB Biotech AG 3-1 Month Momentum % Related Terms

XSWX:BION vs VRTX, REGN, ALNY: 3-1 Month Momentum % Comparison

For the Biotechnology subindustry, BB Biotech AG's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BB Biotech AG 3-1 Month Momentum % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BB Biotech AG's 3-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where BB Biotech AG's 3-1 Month Momentum % falls into.


XSWX:BION
34GF Score
BB Biotech AG XSWX:BION
3-1 Month Momentum % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BB Biotech AG  (XSWX:BION) 3-1 Month Momentum % Calculation

3-1 Month Momentum % is calculated as following:

3-1 Month Momentum %=( Price 1-month ago / Price 3-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 3-1 Month Momentum % →
What does a 3-1 Month Momentum % of -6.25% mean?
BB Biotech AG (XSWX:BION) has a 3-1 Month Momentum % of -6.25% as of Jul. 15, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on BB Biotech AG and its competitors. According to the industry distribution chart, BB Biotech AG ranks #609 out of 1385 companies in the Biotechnology industry, placing it in the top 44%.
Is BB Biotech AG's 3-1 Month Momentum % too high?
BB Biotech AG's current 3-1 Month Momentum % is -6.25%. Based on the distribution chart, BB Biotech AG ranks #609 out of 1385 companies in the Biotechnology industry, which is above the industry midpoint. Overall, BB Biotech AG has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does BB Biotech AG's 3-1 Month Momentum % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, BB Biotech AG ranks #609 out of 1385 companies for 3-1 Month Momentum %. This puts BB Biotech AG in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Biotechnology company?
A good 3-1 Month Momentum % depends on the Biotechnology industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on BB Biotech AG and its competitors. BB Biotech AG's current 3-1 Month Momentum % is -6.25%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BB Biotech AG stock overvalued right now?
BB Biotech AG (XSWX:BION) has a current 3-1 Month Momentum % of -6.25%. The current 3-1 Month Momentum % is -6.25%. BB Biotech AG's overall GF Score™ is 34/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For BB Biotech AG (XSWX:BION), the current 3-1 Month Momentum % is -6.25% as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BB Biotech AG Business Description

Address Schwertstrasse 6, Schaffhausen, CHE, CH-8200
BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market, and is one of the investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the healthcare system. Geographically company operates in the USA, Netherlands, Singapore, Great Britain, Canada, Switzerland, Curacao, and British Virgin Island.
34GF Score

Get the complete analysis for XSWX:BION

3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF50.10
Price